TXN and acute myeloid leukemia: Deregulation of WWP1 expression in acute myeloid leukemia (AML) blasts might accelerate TXNIP proteasomal degradation, thus increasing the ability of thioredoxin to buffer ROS, and ultimately favoring leukemic cell survival.